SPPILawsuitsprnewswire

SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Sentiment:Negative (-70)

Summary

(NASDAQ:SPPI) LOS ANGELES, Sept. 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ("Spectrum" or "the Company") (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on September 2, 2025 by prnewswire

    SPPI Investors Have Opportunity to Lead Spectrum Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm | SPPI Stock News | Candlesense